Literature DB >> 24283169

Surgical treatment outcomes of serious chronic tubo-ovarian abscess: a single-center series of 20 cases.

K Nakayama1, M Ishikawa, H Katagiri, A Katagiri, T Ishibashi, K Iida, N Nakayama, K Miyazaki.   

Abstract

In recent years, Shimane University Hospital has begun to see patients with pelvic inflammatory disease (PID) which has become severe and chronic after insufficient conservative treatment in primary or secondary medical care facilities. Serious chronic tubo-ovarian abscess (TOA) is complicated by intraperitoneal inflammatory adhesions to surrounding organs, so that it is difficult to determine the original anatomical position of organs at surgery. Forcible synechotomy can result in damage to the adhering organs and insufficient drainage after surgery can cause recurrence of inflammation. In order to increase the chances for a successful surgical treatment, careful preparation, such as preoperative administration of antibiotics and ureteral stent insertion are necessary. In addition, the chances for recurrence of inflammation can be lessened by thorough intraperitoneal irrigation and insertion of a drainage tube.

Entities:  

Mesh:

Year:  2013        PMID: 24283169

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  3 in total

1.  Chronic tubo-ovarian abscess complicated by hepatic portal venous gas.

Authors:  Sunny Onyeabor; Frederick Cason
Journal:  J Surg Case Rep       Date:  2015-09-10

2.  Endometriosis is a risk factor for recurrent pelvic inflammatory disease after tubo-ovarian abscess surgery.

Authors:  Maria Zografou Themeli; Konstantinos Nirgianakis; Stephanie Neumann; Sara Imboden; M D Mueller
Journal:  Arch Gynecol Obstet       Date:  2022-08-29       Impact factor: 2.493

3.  Emergency surgery for tubo-ovarian abscess identified extended-spectrum beta-lactamase-producing Escherichia coli: the first case presentation revealing causative bacteria.

Authors:  Teppei Tokumaru; Yasuo Shima; Takehiro Okabayashi; Kazutoshi Hayashi; Yorito Yamamoto; Kazuhide Ozaki; Jun Iwata
Journal:  Surg Case Rep       Date:  2015-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.